InvestorsHub Logo
Followers 32
Posts 12666
Boards Moderated 0
Alias Born 08/29/2012

Re: None

Tuesday, 07/12/2022 12:04:12 AM

Tuesday, July 12, 2022 12:04:12 AM

Post# of 402159
SequestOx development is currently paused yet Nasrat just asked the FDA and was approved for another filing fee waiver:

3 year gap and then asked them again.


2021 10-K
- "The FDA has provided guidance for repeated bio-equivalence studies in order to bridge the new formulation to the original SequestOx™ studies and also extended our filing fee waiver until July 2020"

2022 10-K
- "The FDA has provided guidance for repeated bio-equivalence studies in order to bridge the new formulation to the original SequestOx™ studies and also extended our filing fee waiver until July 2023"


------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News